Degree | Type | Year |
---|---|---|
2500253 Biotechnology | OB | 3 |
You can view this information at the end of this document.
It is essential to have a general background in Biochemistry, Molecular Biology, Cell Biology, Microbiology and Immunology.
In this context, the specific learning outcomes (RAs) for this subject are:
- To differentiate viruses, as genetic entities, from living beings (SM16).
- To identify the main discoveries in the history of virology (KM17).
- To recognize the basic elements of the viral structure and genome, relate their role in the viral cycle, and explain their impact on the immune system (KM17).
- To review the constant evolution of viral taxonomy and identify the main viral families (KM17).
- To associate the pathogenesis of diseases caused by some viruses to their symptomatology (KM17).
- To become familiar with the concept of the virome and the host as a holobiont (KM17).
- To understand the evolution of viruses and how new viruses emerge (KM17).
- To apply viral methodology for the design of new indications in nanomedicine and biotechnology (CM17).
1. Nature and multiplication of viruses
The world of viruses. Strict parasitism, multiplication and transmission. Viral disease and the iceberg concept. Viral diversity and virome. The viral particle: dimensions, chemical composition, morphology and nomenclature. Functions of the capsid; stability and recognition. Chemical composition, structure and organization of the viral genome: structural and non-structural genes. The polarity of the nucleic acid. The viral cycle: extra- and intracellular phases. Viral multiplication: productive and non-productive infections. Sequential expression of viral genes. Viruses, mobile genetic elements and living things.
2. Origins of Virology
The hypotheses about the maintenance of life and spontaneous generation. Pasteur's work. Microscopic infectious agents and Koch postulates. The nineteenth century: the discovery of viruses. The tobacco mosaic: the concept of filterable poison. Discovery of animal viruses. 20th century: chemical, structural and genetic characterization of viruses. Relevant facts in the history of Virology. Smallpox eradication and the risk of re-emergence. Clinical and biotechnological aspects of Virology. Bioterrorism.
3. Structure of viral particles
Morphology of viral particles. Architectural study of viral particles: electron microscopy and three-dimensional reconstructions. X-ray diffraction: resolution level. Molecular architecture in helical and icosahedral symmetries. Trans-membrane proteins in viral envelopes. Receptor- binding sites. Viral antigens and epitopes B and T. Neutralization and evasion of neutralization. Genetic and epitopic variability.
4. Viral genetics and viral genomes
Diversity of viral genomes. Principle of economics and complexity of viral genomes; gene overlapping. Segmented and split genomes. Information encoding the viral genome. Viral genome types and gene expression and replication strategies; time-regulation strategies. The infectious clone. Principles of reverse genetics. Defective viruses.
5. Methods in Virology
Obtaining viral particles. Cell culture at small and medium scale. Purification. Quantitative and qualitative analysis of viral particles. Detection of viral components and applications in diagnostic methodology. The Virology laboratory: areas and distribution. Biological safety. Containment levels: P1 to P4. Air treatment. Effluent treatment.
6. Principles of viral taxonomy
First virus classifications: Baltimore classification of animal viruses. The International Committee on Taxonomy of Viruses and the classification system. Viral properties used in taxonomy. Families of animal viruses and unclassified viruses. Nomenclature changes. Main human pathogens and their diseases.
7. Viral multiplication
Cell recognition. Nature and function of receptors. Internalization. Disassembly. Biosynthetic shutdown. Stimulation of cellular functions: papovaviruses and adenoviruses. RNA, DNA and viral protein synthesis: time sequences. Cytopathic effects. Exit of viral particles with and without lysis. Apoptosis. Cell transformation into RNA viruses: cellular oncogenes; activation and transduction. Cell transformation into DNA viruses: oncogenes and viral oncoproteins. Viral protein processing. Antiviral drug targets. Interfering RNA.
8. Pathogenesis of viral infections
"Good" viruses. Virus-host coexistence. Asymptomatic infections. Characteristics of viral infections. Entrance gates. Transmission routes: horizontal and vertical. Localized and systemic infections. Dissemination. Viremia. Nerve transmission. Target tissues: tropism. Acute and persistent infections. Dissemination. Viremia. Nerve transmission. Target tissues: tropism. Acute and persistent infections. Latent infections. Viral and non-viral factors influencing pathogenesis. Virulence. Evasion of the immune responseby viruses. Immunopathology.
9. Response to viral infections and vaccines
Types of vaccines; attenuated and inactivated. Molecular basis of attenuation. New generation vaccines. Recombinant vaccines and synthetic peptides. Vaccination with nucleic acids. New vectors in vaccines. SARS-CoV-2 vaccines. Herd immunity. Innate and adaptive immune response. Sentinel cells, complement, inflammation, interferons. Communication between innate and adaptive response. Adaptive immune response: humoral and cellular. The importance of the antiviral cellular immune response. The bacterial immune system CRISPR / Cas.
10. Origin and evolution of viruses
Origin of viruses; regressive theories and those in favor of a cellular origin. Mechanisms for the generation of diversity. Mutation frequencies and relative abundance of mutants. Fixation of mutations. Viral replicases and fidelity of copy. Variability and evolution in RNA and retrovirus viruses. Viral quasi-species. Evolution and evolutionary potential. Darwinian and non-Darwinian selection of mutations. Foundational effects and bottlenecks.
11. New viral diseases and emerging viruses
Emergence of new viral diseases. Host jump and viral reservoirs. Viral emergency and re-emergence. Determining environmental, social and technological factors. Importance of arthropod vectors. The human species as a terminal host. New viruses and emerging viral diseases. Hemorrhagic fevers. Ebola virus and human immunodeficiency virus. The continuous re-emergence of the influenza virus.
12. The virome
The concept of virome and methods for its study. Viruses in the planet. The iceberg concept and the Global Virome Project. Acquisition of viruses in humans. Horizontal transmission of the viruses. The horizontal transmission of phenotypes. The human holobiont. The role of the virome in biology of the holobiont, in health and disease. Virome and sexuality.
13. Peculiar infectious agents
Prions: Infectious proteins. Development of the concept of prion. The amyloid. PrPc synthesis and processing. PrPsc formation and prion propagation. Spongiform encephalopathies: inheritance and infection. Phenotypic diversity of prions; the strains. "Scrapie" and bovine spongiform encephalopathy. Interspecific barriers. Human spongiform encephalopathies: Kuru, Creutzfeldt-Jakob syndrome and hereditary diseases. Prions in yeast. Viroids: structure and constancy of domains. Possible mechanisms of pathogenesis. The Satellites. The delta hepatitis virus. Virophages.
14. Bacteriophages
Use of bacteriophages in molecular genetics and biotechnology. The "phage display". The generation of antibodies without immunization and the search for new ligands. Directed molecular evolution. Drug selection systems.
15. Artificial viruses
Viruses as new manipulable nanomaterials. Viral gene therapy; important features and biological risks. Gene therapy products on the market. Artificial viruses as alternatives to viral gene therapy. Kinds of artificial viruses and biomolecules used. Modular strategies. Selection of virus-inspired functional domains. Examples and applications of artificial viruses.
Title | Hours | ECTS | Learning Outcomes |
---|---|---|---|
Type: Directed | |||
Classroom or remote classes | 42 | 1.68 | CM17, KM17, SM16 |
Type: Supervised | |||
Preparing public presentation of projects | 50 | 2 | CM17, KM17, SM16 |
Type: Autonomous | |||
Study | 20 | 0.8 | CM17, KM17, SM16 |
Texts reading | 30 | 1.2 | CM17, KM17, SM16 |
The subject will be taught through lectures and active learning with activities and scientific cases, in which students acquire skills in bibliographic research, experimental approaches and problem solving. Students will do oral presentations derived from practical work, and teamwork will be encouraged, as well as activities' coordination and rational presentation of work projects and results. It will be focused on methodological aspects as well as in biomedical, biotechnological, pharmacological and nanotecnology applications of virus and derived structures.
“*The proposed teaching methodology may experience some modifications depending on the restrictions to face-to-face activities enforced by health authorities.”
Annotation: Within the schedule set by the centre or degree programme, 15 minutes of one class will be reserved for students to evaluate their lecturers and their courses or modules through questionnaires.
Title | Weighting | Hours | ECTS | Learning Outcomes |
---|---|---|---|---|
Final exam: third partial + synthesis exam. Multiple choice | 40% | 2 | 0.08 | CM17, KM17, SM16 |
Midterm exams multiple choice | 30% | 3 | 0.12 | CM17, KM17, SM16 |
Oral presentations and/or written projects | 30% | 3 | 0.12 | CM17, KM17, SM16 |
The remedial exam will be a multiple-choice test and will have questions from the entire syllabus. The exam will be open to students who have failed in the global score of the subject, but also to those who want to improve their scores. Prior registration is required. Separate remedial exams for each part examination cannot be made. The remedial will cover the whole subject and the score obtained will be that of the recovery exam (70%), regardless of the scores obtained in the previous exams. In compliance with article 112 ter point 2 of the current Academic Regulations of the UAB, to be eligible for the remedial test, students must have been previously evaluated in a set of activities equaling at least two thirds of the final qualification of the course. Therefore, the students will obtain the "No Avaluable" qualification when the evaluation activities carried out have a weight lower than 67% in the final score.
For those who have voluntarily chosen the single evaluation, this will consist of a single multiple-choice exam in which the contents of the entire program of theory and seminars of the subject will be evaluated. The score obtained in this test will account for 70% of the final score. The single evaluation test will coincide in the calendar with the last test of the continuous evaluation and the same remedial test will be applied. The evaluation of the seminars will follow the same process than the continuous evaluation and thescore obtained will represent 30% of the final score of the subject.
B.W.J. Mahy and M.H.V. van Regenmortel. 2008. Encyclopedia of virology. 3rd Ed. Academic Press, San Diego. https://bibcercador.uab.cat/permalink/34CSUC_UAB/1eqfv2p/alma991010399827606709
A. J. Cann. 2012. Principles of molecular virology. 5th Ed. Academic Press, Waltham, MA. https://bibcercador.uab.cat/permalink/34CSUC_UAB/1c3utr0/cdi_askewsholts_vlebooks_9780128227855
S.J. Flint, G.F. Rall, V.R. Racaniello, A.M. Skalka, L.W. Enquist. 2015. Principles of virology, V.1, ASM Press, Washington DC. https://bibcercador.uab.cat/permalink/34CSUC_UAB/1c3utr0/cdi_proquest_ebookcentral_EBC6037145
S.J. Flint, G.F. Rall, V.R. Racaniello, A.M. Skalka, L.W. Enquist. 2015. Principles of virology, V.2, ASM Press, Washington, DC. https://bibcercador.uab.cat/permalink/34CSUC_UAB/1c3utr0/cdi_proquest_ebookcentral_EBC6029122
N.J. Dimmock, A.J. Easton and K.N. Leppard. 2016. Introduction to modern virology. 7th Ed. John Wiley & Sons. https://bibcercador.uab.cat/permalink/34CSUC_UAB/1c3utr0/cdi_askewsholts_vlebooks_9781119094531
Richard L. Hodinka; Stephen A. Young; Benjamin A. Pinksy. 2016. Clinical Virology Manual. 5th edition. Washington DC. ASM Press. https://bibcercador.uab.cat/permalink/34CSUC_UAB/avjcib/alma991010361518806709
A. Martín González, V. Béjar, J.C. Gutiérrez, M. Llagostera, E. Quesada. 2019. Microbiología esencial. Editorial Médica Panamericana, Buenos Aires. https://bibcercador.uab.cat/permalink/34CSUC_UAB/1eqfv2p/alma991009862179706709
E. Domingo. 2015. Virus as Populations: Composition, Complexity, Dynamics, and Biological Implications. AcademicPress. https://bibcercador.uab.cat/permalink/34CSUC_UAB/1eqfv2p/alma991010883807106709
I.W. Fong. 2017. Emerging Zoonoses: A Worldwide Perspective. Springer. https://bibcercador.uab.cat/permalink/34CSUC_UAB/1eqfv2p/alma991000748579706709
G. Rezza, G. Ippolito. 2017. Emerging and Re-emerging Viral Infections: Advances in Microbiology, Infectious Diseases and Public Health Volume 6. Springer. https://bibcercador.uab.cat/permalink/34CSUC_UAB/1eqfv2p/alma991000442979706709
P. Tennant, G. Fermin, J.E. Foster. 2018. Viruses: molecular biology, host interactions, and applications to biotechnology. Academic Press. https://bibcercador.uab.cat/permalink/34CSUC_UAB/1eqfv2p/alma991010913781806709
A. Granoffand R.G. Webster. (Constantment actualitzada i ampliada). Encyclopedia of virology (on-line Ed.) Academic Press. London.
(http://www.sciencedirect.com/science/referenceworks/9780123744104)
S. Howley, D. Knipe, S. Whelan, Fields VIROLOGY- Vol. 1. Emerging Viruses. 7th Edition. Wolters Kluver, 2021
G. Fermin, 2018. Viruses. Elsevier. https://mirades.uab.cat/ebs/items/show/155194
Bamford, Dennis, and Mark A. Zuckerman, eds. Encyclopedia of Virology / Editors-in-Chief, Dennis Bamford, Mark A. Zuckerman. Fourth edition. Amsterdam: Academic Press, 2021. https://bibcercador.uab.cat/permalink/34CSUC_UAB/1eqfv2p/alma991010400654406709
It is not necessary to use specific programs in this subject.
Name | Group | Language | Semester | Turn |
---|---|---|---|---|
(TE) Theory | 43 | Spanish | second semester | morning-mixed |